Asmodee – Consensus estimates Q1 2025
5 augusti, 16:00
5 augusti, 16:00
Estimates compiled by Modular Finance on behalf of Asmodee.
Number of contributors: 8 (all of which have been updated or confirmed before the report)
KPI (MEUR, unless otherwise specified) | Q2 2025E |
Net sales | 304 |
Organic growth (%) | 15.33 |
Operating profit/loss | 10.4 |
Net profit/loss | -0.1 |
Adjusted EBITDA | 31.4 |
Adjusted EBITDA margin (%) | 10.31 |
Adjusted EBIT | 23.9 |
Adjusted EBIT margin (%) | 7.85 |
More consensus estimates can be found on Asmodee’s webpage: https://corporate.asmodee.com/the-share#consensus
Asmodee’s Q1 report will be released on Friday 8 August 2025 at 7:00 CEST.
Attachments
Asmodee – Consensus estimates Q1 2025
5 augusti, 16:00
Estimates compiled by Modular Finance on behalf of Asmodee.
Number of contributors: 8 (all of which have been updated or confirmed before the report)
KPI (MEUR, unless otherwise specified) | Q2 2025E |
Net sales | 304 |
Organic growth (%) | 15.33 |
Operating profit/loss | 10.4 |
Net profit/loss | -0.1 |
Adjusted EBITDA | 31.4 |
Adjusted EBITDA margin (%) | 10.31 |
Adjusted EBIT | 23.9 |
Adjusted EBIT margin (%) | 7.85 |
More consensus estimates can be found on Asmodee’s webpage: https://corporate.asmodee.com/the-share#consensus
Asmodee’s Q1 report will be released on Friday 8 August 2025 at 7:00 CEST.
Attachments
Asmodee – Consensus estimates Q1 2025
Fonder
Konjunktur
Novo Nordisk
Aktieråd
Analys
Fonder
Konjunktur
Novo Nordisk
Aktieråd
Analys
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 566,53